{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:08:13Z","timestamp":1770894493310,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T00:00:00Z","timestamp":1428883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T00:00:00Z","timestamp":1428883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2016,1,21]]},"DOI":"10.1038\/onc.2015.91","type":"journal-article","created":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T16:27:00Z","timestamp":1428942420000},"page":"366-376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease"],"prefix":"10.1038","volume":"35","author":[{"given":"C","family":"Ge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Pannone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Bufo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Sanguedolce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Tortorella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Mattoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Papagerakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E T","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R T","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,13]]},"reference":[{"key":"BFonc201591_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. Cancer statistics, 2008. CA. Cancer J Clin 2008; 58: 71\u201396.","journal-title":"Cancer J Clin"},{"key":"BFonc201591_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrc1528","volume":"5","author":"CJ Logothetis","year":"2005","unstructured":"Logothetis CJ, Lin SH . Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer 2005; 5: 21\u201328.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201591_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s10555-006-9032-0","volume":"25","author":"J Pratap","year":"2006","unstructured":"Pratap J, Lian JB, Javed A, Barnes GL, van Wijnen AJ, Stein JL et al. Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev 2006; 25: 589\u2013600.","journal-title":"Cancer Metastasis Rev"},{"key":"BFonc201591_CR4","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0092-8674(00)80259-7","volume":"89","author":"F Otto","year":"1997","unstructured":"Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997; 89: 765\u2013771.","journal-title":"Cell"},{"key":"BFonc201591_CR5","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1158\/1078-0432.CCR-08-3157","volume":"15","author":"CW Chua","year":"2009","unstructured":"Chua CW, Chiu YT, Yuen HF, Chan KW, Man K, Wang X et al. Suppression of androgen-independent prostate cancer cell aggressiveness by FTY720: validating Runx2 as a potential antimetastatic drug screening platform. Clin Cancer Res 2009; 15: 4322\u20134335.","journal-title":"Clin Cancer Res"},{"key":"BFonc201591_CR6","first-page":"1","volume":"2009","author":"J Akech","year":"2009","unstructured":"Akech J, Wixted J, Bedard K, Van der Bedard K, Hussain S, Guise T et al. Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene 2009; 2009: 1\u201311.","journal-title":"Oncogene"},{"key":"BFonc201591_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1476-4598-11-66","volume":"11","author":"A Gupta","year":"2012","unstructured":"Gupta A, Cao W, Chellaiah MA . Integrin alphavbeta3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2\/Smad 5\/receptor activator of NF-kappaB ligand signaling axis. Mol Cancer 2012; 11: 66.","journal-title":"Mol Cancer"},{"key":"BFonc201591_CR8","doi-asserted-by":"publisher","first-page":"7795","DOI":"10.1158\/0008-5472.CAN-08-1078","volume":"68","author":"J Pratap","year":"2008","unstructured":"Pratap J, Wixted JJ, Gaur T, Zaidi SK, Dobson J, Gokul KD et al. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells. Cancer Res 2008; 68: 7795\u20137802.","journal-title":"Cancer Res"},{"key":"BFonc201591_CR9","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/jcb.22463","volume":"109","author":"M van der Deen","year":"2010","unstructured":"van der Deen M, Akech J, Wang T, FitzGerald TJ, Altieri DC, Languino LR et al. The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGFbeta in prostate cancer cells. J Cell Biochem 2010; 109: 828\u2013837.","journal-title":"J Cell Biochem"},{"key":"BFonc201591_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0925-4773(01)00428-2","volume":"106","author":"E Zelzer","year":"2001","unstructured":"Zelzer E, Glotzer DJ, Hartmann C, Thomas D, Fukai N, Soker S et al. Tissue specific regulation of VEGF expression during bone development requires Cbfa1\/Runx2. Mech Dev 2001; 106: 97\u2013106.","journal-title":"Mech Dev"},{"key":"BFonc201591_CR11","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1158\/0008-5472.CAN-07-0433","volume":"67","author":"M Stewart","year":"2007","unstructured":"Stewart M, Mackay N, Hanlon L, Blyth K, Scobie L, Cameron E et al. Insertional mutagenesis reveals progression genes and checkpoints in MYC\/Runx2 lymphomas. Cancer Res 2007; 67: 5126\u20135133.","journal-title":"Cancer Res"},{"key":"BFonc201591_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nrc1607","volume":"5","author":"K Blyth","year":"2005","unstructured":"Blyth K, Cameron ER, Neil JC . The RUNX genes: gain or loss of function in cancer. Nat Rev Cancer 2005; 5: 376\u2013387.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201591_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bcmd.2010.05.007","volume":"45","author":"K Blyth","year":"2010","unstructured":"Blyth K, Vaillant F, Jenkins A, McDonald L, Pringle MA, Huser C et al. Runx2 in normal tissues and cancer cells: A developing story. Blood Cells Mol Dis 2010; 45: 117\u2013123.","journal-title":"Blood Cells Mol Dis"},{"key":"BFonc201591_CR14","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1002\/ijc.22071","volume":"119","author":"NY Cho","year":"2006","unstructured":"Cho NY, Choi M, Kim BH, Cho YM, Moon KC, Kang GH . BRAF and KRAS mutations in prostatic adenocarcinoma. Int J Cancer 2006; 119: 1858\u20131862.","journal-title":"Int J Cancer"},{"key":"BFonc201591_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010; 18: 11\u201322.","journal-title":"Cancer Cell"},{"key":"BFonc201591_CR16","first-page":"279","volume":"59","author":"D Gioeli","year":"1999","unstructured":"Gioeli D, Mandell JW, Petroni GR, Frierson HF Jr., Weber MJ . Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res 1999; 59: 279\u2013284.","journal-title":"Cancer Res"},{"key":"BFonc201591_CR17","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1158\/0008-5472.CAN-11-3132","volume":"72","author":"DJ Mulholland","year":"2012","unstructured":"Mulholland DJ, Kobayashi N, Ruscetti M, Zhi A, Tran LM, Huang J et al. Pten loss and RAS\/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem\/progenitor cells. Cancer Res 2012; 72: 1878\u20131889.","journal-title":"Cancer Res"},{"key":"BFonc201591_CR18","doi-asserted-by":"publisher","first-page":"e3949","DOI":"10.1371\/journal.pone.0003949","volume":"3","author":"JH Jeong","year":"2008","unstructured":"Jeong JH, Wang Z, Guimaraes AS, Ouyang X, Figueiredo JL, Ding Z et al. BRAF activation initiates but does not maintain invasive prostate adenocarcinoma. PLoS ONE 2008; 3: e3949.","journal-title":"PLoS ONE"},{"key":"BFonc201591_CR19","doi-asserted-by":"publisher","first-page":"7789","DOI":"10.1073\/pnas.0602567103","volume":"103","author":"L Xin","year":"2006","unstructured":"Xin L, Teitell MA, Lawson DA, Kwon A, Mellinghoff IK, Witte ON . Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor. Proc Natl Acad Sci USA 2006; 103: 7789\u20137794.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201591_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1593\/neo.06694","volume":"9","author":"YM Chang","year":"2007","unstructured":"Chang YM, Kung HJ, Evans CP . Nonreceptor tyrosine kinases in prostate cancer. Neoplasia 2007; 9: 90\u2013100.","journal-title":"Neoplasia"},{"key":"BFonc201591_CR21","doi-asserted-by":"publisher","first-page":"32533","DOI":"10.1074\/jbc.M109.040980","volume":"284","author":"C Ge","year":"2009","unstructured":"Ge C, Xiao G, Jiang D, Yang Q, Hatch NE, Roca H et al. Identification and functional characterization of ERK\/MAPK phosphorylation sites in the Runx2 transcription factor. J Biol Chem 2009; 284: 32533\u201332543.","journal-title":"J Biol Chem"},{"key":"BFonc201591_CR22","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1074\/jbc.275.6.4453","volume":"275","author":"G Xiao","year":"2000","unstructured":"Xiao G, Jiang D, Thomas P, Benson MD, Guan K, Karsenty G et al. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J Biol Chem 2000; 275: 4453\u20134459.","journal-title":"J Biol Chem"},{"key":"BFonc201591_CR23","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1083\/jcb.200610046","volume":"176","author":"C Ge","year":"2007","unstructured":"Ge C, Xiao G, Jiang D, Franceschi RT . Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J Cell Biol 2007; 176: 709\u2013718.","journal-title":"J Cell Biol"},{"key":"BFonc201591_CR24","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1172\/JCI42285","volume":"120","author":"MB Greenblatt","year":"2010","unstructured":"Greenblatt MB, Shim JH, Zou W, Sitara D, Schweitzer M, Hu D et al. The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J Clin Invest 2010; 120: 2457\u20132473.","journal-title":"J Clin Invest"},{"key":"BFonc201591_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1359\/jbmr.090705","volume":"25","author":"Y Li","year":"2010","unstructured":"Li Y, Ge C, Franceschi RT . Differentiation-dependent association of phosphorylated extracellular signal-regulated kinase with the chromatin of osteoblast-related genes. J Bone Miner Res 2010; 25: 154\u2013163.","journal-title":"J Bone Miner Res"},{"key":"BFonc201591_CR26","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/jbmr.561","volume":"27","author":"C Ge","year":"2012","unstructured":"Ge C, Yang Q, Zhao G, Yu H, Kirkwood KL, Franceschi RT . Interactions between extracellular signal-regulated kinase 1\/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity. J Bone Miner Res 2012; 27: 538\u2013551.","journal-title":"J Bone Miner Res"},{"key":"BFonc201591_CR27","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/jbmr.1574","volume":"27","author":"Y Li","year":"2012","unstructured":"Li Y, Ge C, Long JP, Begun DL, Rodriguez JA, Goldstein SA et al. Biomechanical stimulation of osteoblast gene expression requires phosphorylation of the RUNX2 transcription factor. J Bone Miner Res 2012; 27: 1263\u20131274.","journal-title":"J Bone Miner Res"},{"key":"BFonc201591_CR28","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/S0022-5347(17)53345-5","volume":"128","author":"JL Ware","year":"1982","unstructured":"Ware JL, Paulson DF, Mickey GH, Webb KS . Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice. J Urol 1982; 128: 1064\u20131067.","journal-title":"J Urol"},{"key":"BFonc201591_CR29","first-page":"2577","volume":"54","author":"GN Thalmann","year":"1994","unstructured":"Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL et al. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 1994; 54: 2577\u20132581.","journal-title":"Cancer Res"},{"key":"BFonc201591_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10555-007-9104-9","volume":"27","author":"PY Wai","year":"2008","unstructured":"Wai PY, Kuo PC . Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev 2008; 27: 103\u2013118.","journal-title":"Cancer Metastasis Rev"},{"key":"BFonc201591_CR31","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/sj.onc.1202064","volume":"17","author":"M Sato","year":"1998","unstructured":"Sato M, Morii E, Komori T, Kawahata H, Sugimoto M, Terai K et al. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA\/CBFA1 and ETS1 in the skeletal tissues. Oncogene 1998; 17: 1517\u20131525.","journal-title":"Oncogene"},{"key":"BFonc201591_CR32","doi-asserted-by":"crossref","first-page":"23933","DOI":"10.1016\/S0021-9258(20)80474-8","volume":"268","author":"CF Zheng","year":"1993","unstructured":"Zheng CF, Guan KL . Properties of MEKs, the kinases that phosphorylate and activate the extracellular signal-regulated kinases. J Biol Chem 1993; 268: 23933\u201323939.","journal-title":"J Biol Chem"},{"key":"BFonc201591_CR33","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1158\/0008-5472.CAN-10-2603","volume":"71","author":"H Zhang","year":"2011","unstructured":"Zhang H, Pan Y, Zheng L, Choe C, Lindgren B, Jensen ED et al. FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion. Cancer Res 2011; 71: 3257\u20133267.","journal-title":"Cancer Res"},{"key":"BFonc201591_CR34","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/carcin\/18.6.1215","volume":"18","author":"D Bello","year":"1997","unstructured":"Bello D, Webber MM, Kleinman HK, Wartinger DD, Rhim JS . Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis 1997; 18: 1215\u20131223.","journal-title":"Carcinogenesis"},{"key":"BFonc201591_CR35","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1002\/jcb.23289","volume":"112","author":"TG Kwon","year":"2011","unstructured":"Kwon TG, Zhao X, Yang Q, Li Y, Ge C, Zhao G et al. Physical and functional interactions between Runx2 and HIF-1alpha induce vascular endothelial growth factor gene expression. J Cell Biochem 2011; 112: 3582\u20133593.","journal-title":"J Cell Biochem"},{"key":"BFonc201591_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcb.20411","volume":"95","author":"M Zhao","year":"2005","unstructured":"Zhao M, Zhao Z, Koh JT, Jin T, Franceschi RT . Combinatorial gene therapy for bone regeneration: cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7. J Cell Biochem 2005; 95: 1\u201316.","journal-title":"J Cell Biochem"},{"key":"BFonc201591_CR37","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/bjc.2012.455","volume":"107","author":"G Browne","year":"2012","unstructured":"Browne G, Nesbitt H, Ming L, Stein GS, Lian JB, McKeown SR et al. Bicalutamide-induced hypoxia potentiates RUNX2-mediated Bcl-2 expression resulting in apoptosis resistance. Br J Cancer 2012; 107: 1714\u20131721.","journal-title":"Br J Cancer"},{"key":"BFonc201591_CR38","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/jcp.20469","volume":"206","author":"SM Pockwinse","year":"2006","unstructured":"Pockwinse SM, Rajgopal A, Young DW, Mujeeb KA, Nickerson J, Javed A et al. Microtubule-dependent nuclear-cytoplasmic shuttling of Runx2. J Cell Physiol 2006; 206: 354\u2013362 C.","journal-title":"J Cell Physiol"},{"key":"BFonc201591_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/pcan.2012.31","volume":"15","author":"SJ Yun","year":"2012","unstructured":"Yun SJ, Yoon HY, Bae SC, Lee OJ, Choi YH, Moon SK et al. Transcriptional repression of RUNX2 is associated with aggressive clinicopathological outcomes, whereas nuclear location of the protein is related to metastasis in prostate cancer. Prostate Cancer Prostatic Dis 2012; 15: 369\u2013373.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"BFonc201591_CR40","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1128\/MCB.16.7.3967","volume":"16","author":"T Tanaka","year":"1996","unstructured":"Tanaka T, Kurokawa M, Ueki K, Tanaka K, Imai Y, Mitani K et al. The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability. Mol Cell Biol 1996; 16: 3967\u20133979.","journal-title":"Mol Cell Biol"},{"key":"BFonc201591_CR41","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/eji.201040746","volume":"42","author":"M Yoshimi","year":"2012","unstructured":"Yoshimi M, Goyama S, Kawazu M, Nakagawa M, Ichikawa M, Imai Y et al. Multiple phosphorylation sites are important for RUNX1 activity in early hematopoiesis and T-cell differentiation. Eur J Immunol 2012; 42: 1044\u20131050.","journal-title":"Eur J Immunol"},{"key":"BFonc201591_CR42","doi-asserted-by":"publisher","first-page":"10122","DOI":"10.1074\/jbc.M109.071381","volume":"285","author":"YM Goh","year":"2010","unstructured":"Goh YM, Cinghu S, Hong ET, Lee YS, Kim JH, Jang JW et al. Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm. J Biol Chem 2010; 285: 10122\u201310129.","journal-title":"J Biol Chem"},{"key":"BFonc201591_CR43","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/jcb.21906","volume":"105","author":"HR Kim","year":"2008","unstructured":"Kim HR, Oh BC, Choi JK, Bae SC . Pim-1 kinase phosphorylates and stabilizes RUNX3 and alters its subcellular localization. J Cell Biochem 2008; 105: 1048\u20131058.","journal-title":"J Cell Biochem"},{"key":"BFonc201591_CR44","doi-asserted-by":"publisher","first-page":"7118","DOI":"10.1074\/jbc.M508162200","volume":"281","author":"M Qiao","year":"2006","unstructured":"Qiao M, Shapiro P, Fosbrink M, Rus H, Kumar R, Passaniti A . Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation. J Biol Chem 2006; 281: 7118\u20137128.","journal-title":"J Biol Chem"},{"key":"BFonc201591_CR45","doi-asserted-by":"publisher","first-page":"e1058","DOI":"10.1371\/journal.pone.0001058","volume":"2","author":"N Kawamura","year":"2007","unstructured":"Kawamura N, Kugimiya F, Oshima Y, Ohba S, Ikeda T, Saito T et al. Akt1 in osteoblasts and osteoclasts controls bone remodeling. PLoS ONE 2007; 2: e1058.","journal-title":"PLoS ONE"},{"key":"BFonc201591_CR46","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1074\/jbc.275.7.5037","volume":"275","author":"N Selvamurugan","year":"2000","unstructured":"Selvamurugan N, Pulumati MR, Tyson DR, Partridge NC . Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor alpha1. J Biol Chem 2000; 275: 5037\u20135042.","journal-title":"J Biol Chem"},{"key":"BFonc201591_CR47","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1002\/jcp.24339","volume":"228","author":"S Pande","year":"2013","unstructured":"Pande S, Browne G, Padmanabhan S, Zaidi SK, Lian JB, van Wijnen AJ et al. Oncogenic cooperation between PI3K\/Akt signaling and transcription factor Runx2 promotes the invasive properties of metastatic breast cancer cells. J Cell Physiol 2013; 228: 1784\u20131792.","journal-title":"J Cell Physiol"},{"key":"BFonc201591_CR48","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/modpathol.2009.69","volume":"22","author":"B Han","year":"2009","unstructured":"Han B, Mehra R, Lonigro RJ, Wang L, Suleman K, Menon A et al. Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression. Mod Pathol 2009; 22: 1083\u20131093.","journal-title":"Mod Pathol"},{"key":"BFonc201591_CR49","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1535-6108(03)00215-0","volume":"4","author":"S Wang","year":"2003","unstructured":"Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 2003; 4: 209\u2013221.","journal-title":"Cancer Cell"},{"key":"BFonc201591_CR50","doi-asserted-by":"publisher","first-page":"E3506","DOI":"10.1073\/pnas.1303558110","volume":"110","author":"A Aytes","year":"2013","unstructured":"Aytes A, Mitrofanova A, Kinkade CW, Lefebvre C, Lei M, Phelan V et al. ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer. Proc Natl Acad Sci USA 2013; 110: E3506\u2013E3515.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201591_CR51","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/labinvest.2009.128","volume":"90","author":"M Lim","year":"2010","unstructured":"Lim M, Zhong C, Yang S, Bell AM, Cohen MB, Roy-Burman P . Runx2 regulates survivin expression in prostate cancer cells. Lab Invest 2010; 90: 222\u2013233.","journal-title":"Lab Invest"},{"key":"BFonc201591_CR52","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/0022034508328072","volume":"88","author":"S Fatherazi","year":"2009","unstructured":"Fatherazi S, Matsa-Dunn D, Foster BL, Rutherford RB, Somerman MJ, Presland RB . Phosphate regulates osteopontin gene transcription. J Dent Res 2009; 88: 39\u201344.","journal-title":"J Dent Res"},{"key":"BFonc201591_CR53","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.1128\/MCB.18.7.4197","volume":"18","author":"K Thirunavukkarasu","year":"1998","unstructured":"Thirunavukkarasu K, Mahajan M, McLarren KW, Stifani S, Karsenty G . Two domains unique to osteoblast-specific transcription factor Osf2\/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta. Mol Cell Biol 1998; 18: 4197\u20134208.","journal-title":"Mol Cell Biol"},{"key":"BFonc201591_CR54","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1593\/neo.08154","volume":"10","author":"AM Havens","year":"2008","unstructured":"Havens AM, Pedersen EA, Shiozawa Y, Ying C, Jung Y, Sun Y et al. An in vivo mouse model for human prostate cancer metastasis. Neoplasia 2008; 10: 371\u2013380.","journal-title":"Neoplasia"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc201591.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201591","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201591.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T10:50:50Z","timestamp":1717843850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc201591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,13]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,1,21]]}},"alternative-id":["BFonc201591"],"URL":"https:\/\/doi.org\/10.1038\/onc.2015.91","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,13]]},"assertion":[{"value":"13 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}